Baricitinib for the treatment of patients with severe alopecia areata

NICE

28 February 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of baricitinib in the NHS in England.

For the time being, baricitinib is not recommended for the treatment of adults with severe alopecia areata.

Read draft guidance consultation

Michael Wonder

Posted by:

Michael Wonder